Force is Never Justified
The discovery was made by Christopher Martens, assistant professor of kinesiology and applied physiology and director of the Delaware Center for Cognitive Aging Research,
Israeli scientists gave an artificial molecule they invented to 30 mice suffering from Alzheimer’s — and found that all of
Research into the disease has focused on plaques in the brain. But some scientists think viruses and bacteria play a
Continue readingCould Alzheimer’s be caused by an infection? | Alzheimer’s | The Guardian
The U.S. Food and Drug Administration approved Leqembi, from Japanese drugmaker Eisai, in early January. It’s for patients with mild
Continue readingWhy a new Alzheimer’s drug is having a slow US debut – ABC News
But doctors and health experts are divided on whether it warranted an accelerated FDA approval. While some of them have
The new Alzheimer’s treatment Leqembi will cost an estimated $26,500 per year, according to Eisai, the company that led the
Continue readingAlzheimer’s treatment: Patients would pay up to $26,500 per year for Leqembi
Lecanemab will be marketed as Leqembi, the FDA statement said. It has shown “potential” as an Alzheimer’s disease treatment by
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still,
Continue readingFDA Approves, Leqembi, New Treatment for Early Alzheimer’s – The New York Times
Investigators found “atypical collaboration” between the company and the FDA, saying the federal agency went against its own protocols. The
Continue readingFDA controversy over Biogen’s Alzheimer’s drug Aduhelm, explained
US drug regulators failed to follow their own guidance and practices when they approved the controversial Alzheimer’s drug Aduhelm, a
Continue readingFDA under fire over approval of Alzheimer’s drug Aduhelm | US news | The Guardian